83bar Further Expands Global Patient Activation Capabilities By:83bar, LLC 2019-11-13
AUSTIN, Texas - Nov. 12, 2019 - 83bar has announced continued global expansion of its patient activation capabilities in Europe, through a combination of strategic partnerships and management assignments. According to Bob Baurys, CEO o...
New Partnership for Faster, More Productive Clinical Trials By:Phase Clinical Services 2019-11-12
MANHATTAN, N.Y. - Nov. 11, 2019 - Combining their particular strengths in cutting-edge medical treatments, broad patient access and innovative clinical trial management, this partnership is expected to provide multiple benefits for study&nb...
Tacrolimus Biotin and BSA Conjugates By:Molecular Depot LLC 2019-11-04
SAN DIEGO - Nov. 3, 2019 - Molecular Depot now offers four new Tacrolimus conjugates that can be used in Tacrolimus immuno-detection and Tacrolimus immuno-assay development: • Tacrolimus-(PEG3)-Biotin Conjugate: Tacrolimus is linked to Bi...
Crystallization Screen for Protein-DNA Complexes By:Molecular Depot LLC 2019-11-04
SAN DIEGO - Nov. 3, 2019 - Molecular Depot continues its innovative endeavor in biotech research by introducing the first Crystallization Screen for Protein-DNA Complexes. The screen consists of 48 unique crystallization reagents that ...
Interference Test Kit For Assay Validation By:Molecular Depot LLC 2019-10-28
SAN DIEGO - Oct. 27, 2019 - Molecular Depot LLC now offers an Interference Test Kit containing six endogenous substances to use in assay routine interference testing. Interference Test Kit includes concentrated stock solutions of&...
Rheumatoid Factor Interference Blocker By:Molecular Depot LLC 2019-10-28
SAN DIEGO - Oct. 27, 2019 - Rheumatoid Factor (RF) interference is a major issue when testing the performance of immunoassays. RF and other autoimmune antibodies present in the serum of Rheumatoid Arthritis patients can, pres...
83bar pharma chief Kate Hermans to speak at CNS Summit By:83bar, LLC 2019-10-24
AUSTIN, Texas - Oct. 23, 2019 - Kate Hermans, chief business officer for pharma at 83bar LLC, will present on driving patient empowerment at the 10th annual CNS Summit meeting October 31-November 3, 2019 in Boca Raton,&n...
S-cubed launch the A3 Community MDR By:S-cubed ApS 2019-10-16
COPENHAGEN, Denmark - Oct. 16, 2019 - S-cubed is pleased to announce the launch of the A3 Community MDR provided free for the benefit of the CDISC user community. The A3 Community MDR allows users to browse and ...
Kalos Therapeutics Stengthens Executive Team By:http//KalosTherapeuticsInc.com 2019-10-15
SAN DIEGO - Oct. 14, 2019 - Kalos Therapeutics Strengthens Executive Team Adding Strategic Business Expertise Phoenix, Arizona, October 14th, 2019 -- Kalos Therapeutics announced today that Jamie Jones has joined the company as&...